Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Justin Sullivan/Getty Images

Members of the Food and Drug Administration's vaccine expert panel Tuesday endorsed a two-dose series of Pfizer-BioNTech's COVID-19 vaccine for children ages 5–11. The final vote was 17 members in favor, with one member abstaining.

Why it matters: While not binding, the decision is a long-awaited step toward getting COVID vaccines in the arms of some of the youngest Americans potentially in time to get many fully vaccinated in advance of the holiday season.

By the numbers: Pfizer and BioNTech said their COVID-19 vaccine was more than 90% effective at protecting children ages 5–11 from symptomatic infections from the virus, according to a study posted online by the FDA last week.

Be smart: The advisory committee continuously referred its discussion back to the potential risk-benefit analysis for vaccinating kids, particularly considering the small increased risk of heart inflammation called myocarditis.

  • That was particularly the case due to declining COVID-19 case rates nationwide in recent weeks, as well as potentially at many as 40% of children who may have already some immunity due to a previous infection.
  • Officials said they believe the modeling may overestimate the risks for myocarditis, but several panel members pointed out the lingering questions about the actual rate.

But, but, but: "We've been assuming we're on the descending slope of the curve previously and been caught flat-footed as the rates again went up, so thinking this is going to be the end of the wave permanently may be a little overly optimistic," said Arnold Monto, chairman of the advisory panel.

Several advisory board members indicated they were concerned about approving the vaccine for all children in the age group because potential mandates could come down based on their vote.

  • 'This is a much tougher one than we expected going into this," said advisory board member Eric Rubin, an adjunct professor of immunology and infectious diseases at the Harvard T.H. Chan School of Public Health, of Harvard Medical School.
  • Others raised questions about whether a one-dose regimen would be more appropriate for kids.

But, many of them said they ultimately wanted to make the vaccine available to kids available at the highest risk from COVID, such as those with underlying medical conditions. Many of those kids have been forced to stay home, which comes with its own risks to their wellbeing.

  • The advisory board said they were also concerned about preventing the risks of long COVID in children.
  • "If I were a parent of a child in this age group, I would want to have the choice. We can’t have the choice unless the vaccine is available," said A. Oveta Fuller, an African Studies Center International Institute associate professor of microbiology and immunology at the University of Michigan Medical School.

What we're watching: FDA acting commissioner Janet Woodcock will ultimately make the call on approval. If it does get the OK, it will head to the CDC for consideration next week.

  • The White House said it secured enough vaccine supply to equip more than 25,000 pediatric and primary care offices, hundreds of school and community health clinics, and tens of thousands of pharmacies to administer the shots.

Go deeper

Dec 6, 2021 - Health

CDC raises travel advisories for France, Portugal to highest level amid COVID surge

Angus Mordant/Bloomberg via Getty Images

The Centers for Disease Control and Prevention raised COVID-19 travel advisories to their highest levels for a number of countries on Monday, including France and Portugal.

Why it matters: The detection of the new Omicron variant last month has spurred fears of a new wave of virus infections.

Dec 6, 2021 - Health

Cruise ship COVID outbreak: Louisiana officials find "probable" Omicron case

The Norwegian Breakaway cruise ship. Photo: Gerard Bottino/SOPA Images/LightRocket via Getty Images

Louisiana health authorities said a suspected Omicron case was one of 17 confirmed COVID-19 infections among the passengers and crew of a Norwegian Cruise Lines ship that returned to New Orleans Sunday.

Driving the news: The Norwegian Breakaway departed New Orleans on Nov. 28 with more than 3,200 people on board, before making stops in Belize, Honduras and Mexico, according to a Louisiana Department of Health statement.

Gov. Hochul will order some NY hospitals to halt elective surgeries

New York State Gov. Kathy Hochul COVID-19 addresses rising cases in the state and the new variant Omicron at a press conference in November. Photo: Lev Radin/Pacific Press/LightRocket via Getty Images

New York Gov. Kathy Hochul announced on Monday that some state hospitals will be ordered to halt certain elective surgeries in an effort to combat a recent COVID-19 surge, Hochul said at a press conference.

Why it matters: New York has struggled with hospital capacity throughout the pandemic and postponed nonessential procedures before.